We are live on ! Find out more
DCOY

Decoy Therapeutics
DCOY

5 hedge funds and large institutions have $73.4M invested in Decoy Therapeutics in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

26% less capital invested

Capital invested by funds: $98.6M → $73.4M (-$25.2M)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$13M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$2.06M
2
WSA
Wall Street Associates
California
-$688K
3
AIC
AWM Investment Company
New York
-$430K
4
PAM
Panagora Asset Management
Massachusetts
-$55K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$18K

DCOY Hedge Fund Activity: Q3 2015 in Review

5 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Decoy Therapeutics (DCOY) for Q3 2015, worth a combined $73.4M — down 26% from $98.6M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new DCOY positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Capital World Investors, opening a new position worth an estimated $13M. The largest seller was Visium Asset Management, cutting an estimated $2.06M.

  • 5 institutional investors held Decoy Therapeutics (DCOY) as of Q3 2015, up from 4 in Q2 2015.
  • Funds reported $73.4M of Decoy Therapeutics stock for Q3 2015, down 26% quarter-over-quarter.
  • 1 fund opened new Decoy Therapeutics positions in Q3 2015 and 0 closed out, a net change of +1 holder.
  • The largest Decoy Therapeutics buyer in Q3 2015 was Capital World Investors, an estimated $13M added.
  • The largest Decoy Therapeutics seller in Q3 2015 was Visium Asset Management, an estimated $2.06M sold.

Based on aggregated 13F filings for Q3 2015.